|
【结 构 式】 
|
【分子编号】29175 【品名】4-(acetamido)-5-chloro-2-methoxy-N-(6-methyloctahydro-2H-quinolizin-2-yl)benzamide 【CA登记号】 |
【 分 子 式 】C20H28ClN3O3 【 分 子 量 】393.91344 【元素组成】C 60.98% H 7.16% Cl 9% N 10.67% O 12.18% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(VI)The reaction of quinolizidinone (I) with hydroxylamine and pyridine in refluxing ethanol gives the corresponding oxime (II), which is reduced with LiAlH4 in ether to yield 6-methyl-2-aminoquinolizidine (III). The acylation of (III) with 4-acetamido-5-chloro-2-methoxybenzoyl chloride (IV) [prepared from the corresponding acid (V) and SOCl2] by means of triethylamine in benzene affords the protected benzamide (VI), which is finally deprotected with KOH in refluxing ethanol.
| 【1】 Hadley, M.S.; Watts, E.A. (SmithKline Beecham plc); Treating gastro-intestinal disorders and emesis with n-(heterocyclic substituted)benzamides. BE 0860049; DE 2748260; FR 2370051; GB 1593146; JP 53059692; NL 7712203; US 4213983 . |
| 【2】 Singh, S.K.; Kumar, Y.; Prasad, M.; Prasad, A.; Kumar, N.P. (Ranbaxy Laboratories Ltd.); Process for the preparation of cefdinir. WO 0391261 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 29171 | 6-methyloctahydro-2H-quinolizin-2-one | C10H17NO | 详情 | 详情 | |
| (II) | 29172 | 6-methyloctahydro-2H-quinolizin-2-one oxime | C10H18N2O | 详情 | 详情 | |
| (III) | 29173 | 6-methyloctahydro-2H-quinolizin-2-amine | C10H20N2 | 详情 | 详情 | |
| (IV) | 11631 | 4-(Acetamido)-5-chloro-2-methoxybenzoyl chloride | C10H9Cl2NO3 | 详情 | 详情 | |
| (V) | 29174 | 4-(acetamido)-5-chloro-2-methoxybenzoic acid | C10H10ClNO4 | 详情 | 详情 | |
| (VI) | 29175 | 4-(acetamido)-5-chloro-2-methoxy-N-(6-methyloctahydro-2H-quinolizin-2-yl)benzamide | C20H28ClN3O3 | 详情 | 详情 |
Extended Information